Whitepaper – Protecting Critical Care Drugs


Whitepaper – Protecting Critical Care Drugs

The trafficking of fake and altered drugs, including injectables, has reached epidemic levels in some parts of the world and is a growing problem in the United States.

According to the World Health Organization, 50% of drugs sold online are counterfeit.

What Brand Protection security measures do you have in place to protect your brand against these counterfeit drugs?

In this whitepaper you will learn:

  • Multi-layered solutions for positive identification
  • Importance of tracking products through the supply chain
  • Designs of a proactive, overarching anti-counterfeit strategy


Back To Top